In Vivo is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

ViaCell Neuroscience

Division of PerkinElmer Inc.
www.viacellinc.com

Latest From ViaCell Neuroscience

Aegerion appoints Marc Beer as CEO

Aegerion Pharmaceuticals, a US-based biopharmaceutical company focused on the development and commercialisation of therapeutics to treat severe lipid disorders, has appointed Marc Beer as both CEO and a member of the board of directors. He has more than 20 years experience in biotechnology, pharmaceuticals and diagnostics. In 2000, he became the founding CEO of ViaCell, a biotech company specialising in the collection and preservation of umbilical cord blood stem cells. Mr Beer has also worked for Genzyme and Abbott Laboratories.

Companies

Seaside Therapeutics makes board appointments

Seaside Therapeutics (US) has appointed Marc Beer, former CEO of ViaCell, Karen Dawes, president of Knowledge Decisions, and Dr Steven Paul, former executive vice-president for science and technology at Lilly, to its board of directors. They join Seaside's current board members – the company's president & CEO, Dr Randall Carpenter, and Peter Whipp, managing director of Barony Trust, Seaside's largest investor. Seaside is creating treatments to correct or improve the course of fragile X syndrome, autism and other neurodevelopmental disorders.

Neurology Companies

New CFO at Amarin

John Thero has joined Amarin (Ireland) as chief financial officer. He has more than 20 years' senior financial and operational management experience, having previously served as CFO at ViaCell and Abiomed.

Ireland Companies
See All

Company Information

  • Industry
  • Biotechnology
    • Gene Therapy, Cell Therapy
  • Pharmaceuticals
  • Therapeutic Areas
  • Neurology, Nervous System
  • Alias(es)
  • Cerebrotec Inc.
  • Ownership
  • Private
  • Headquarters
  • Worldwide
    • North America
      • USA
  • Parent & Subsidiaries
  • PerkinElmer Inc.
  • Senior Management
  • Marc D Beer, Chmn. & CEO
    Jeff Sacher, CFO
    Christoph M Adams, PhD, SVP, Bus. Dev.
    Kurt C Gunter, MD, SVP, Clinical & Reg. Affairs
  • Contact Info
  • ViaCell Neuroscience
    Phone: (866) 842-2355
    131 Clarendon St.
    Boston, MA 02116
    USA
UsernamePublicRestriction

Register